of Neuroblastoma

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on of Neuroblastoma

Antibody Type Trials 3F8 (Cheung et al. 2012b) Murine IgG3 Phase I, II 14G2a (Murray et al. 1994) Murine Ig Phase I Ch14.18 (Yu et al. 2010) Chimeric IgG1 Phase…

read more

of Surgery in a Multidisciplinary Approach

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on of Surgery in a Multidisciplinary Approach

Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398; discussion 398–401 (1994) Givi B, Pommier SJ, Thompson AK, Diggs…

read more

Combined with Radionuclide Therapy

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on Combined with Radionuclide Therapy

© Springer-Verlag Berlin Heidelberg 2012Richard P. Baum (ed.)Therapeutic Nuclear MedicineMedical Radiology10.1007/174_2012_740 Chemotherapy Combined with Radionuclide Therapy Phillip G. Claringbold1   and J. Harvey Turner2 (1) Department of Oncology, Fremantle hospital, Alma Street, Fremantle, WA, 6160, Australia (2)…

read more

Impact of Radiation Biology in Radiation Protection in Nuclear Medicine and Corresponding Regulatory Issues

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on Impact of Radiation Biology in Radiation Protection in Nuclear Medicine and Corresponding Regulatory Issues

Fig. 1 a Immunofluorescent labelling of γH2AX foci (green) of non-transformed human skin fibroblasts after 2 Gy irradiation and 4 h repair, b Countercoloration with DAPI (blue) (Courtesy of N. Foray) 4 Nuclear…

read more
Get Clinical Tree app for offline access